"Maine Eye is northern New England's most comprehensive eye specialty practice. Our highly trained physicians and optometrists enjoy helping the people of our region see the world around them. We look forward to providing the care needed for your visual needs. Our commitment to state of the art technology, clinical research and patient centered care is the cornerstone of our mission to the community."

During the past decade, Maine Eye Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maine Eye Center" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Kodiak Sciences Inc" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Maine Eye Center" are "Diabetic Macular Edema" (4 trials), "Geographic Atrophy" (3 trials), "Neovascular Age-Related Macular Degeneration" (2 trials), "Age-Related Maculopathy" (1 trials) and "Corneal Edema After Cataract Surgery" (1 trials). Many other conditions were trialed in "Maine Eye Center" in a lesser frequency.

Most popular intervention types in "Maine Eye Center" are "Drug" (14 trials), "Other" (5 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Faricimab" (4 trials), "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials) and "KSI-301" (2 trials). Other intervention names were less common.

The vast majority of trials in "Maine Eye Center" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Maine Eye Center". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Maine Eye Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Maine Eye Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".